Updates in the Prevention and Treatment of Recurrent Clostridioides difficile Infection Focus on High-Risk Populations

Sign Up For Updates

About This Series

Clostridioides difficile infection (CDI) has increased in incidence and severity over the past two decades to become the most common healthcare associated infection the United States and the most common cause of mortality in patients with gastroenteritis. 

This educational series debates the hottest and most controversial topics in CDI pharmacotherapy including when to use new and emerging therapies and how knowledge of the human microbiome is changing treatment paradigms. Treatment of CDI is evolving with a greater emphasis on prevention of recurrence also known as sustained clinical response. 

Faculty address cost-effective treatment plans that optimize therapy and provide a rational anti-CDI recurrence treatment strategy. Panel discussions highlight current and near future therapeutic targets to prevent CDI recurrence.
 


Part 1: On-Demand Activity

Prevention and Treatment of Recurrent Clostridioides difficile Infection

This 1-hour interprofessional educational activity reviews the epidemiology of recurrent C. difficile infection, current and emerging pharmacologic and non-pharmacologic therapies, and special populations at risk for infection.

Release Date: January 15, 2021
Expiration Date: May 31, 2022

 


Part 2: On-Demand Activity

Preventing and Treating Recurrent Clostridioides difficile Infection in High-Risk Populations:  A Pro/Con Debate
A Virtual Midday Symposium conducted at the 2020 ASHP Midyear Clinical Meeting and Exhibition
(Midyear registration not required)

This 1.5-hour interprofessional educational activity uses a point-counterpoint approach to decision making for managing special patient populations at high-risk for poor outcomes also taking into account cost-benefit considerations.

Release Date:  January 20, 2021
Expiration Date:   May 31, 2022


Engaging the Experts

Hear more about C. difficile and the microbiome with Drs. Garey, Dubberke, and Rao.

Listen to Microbiome 101

Listen to C. Diff Therapeutics


Expert Insight

Practical commentary from our expert faculty to improve patient outcomes and inspire practice changes.